BIOTEKE Respiratory Tract 5-in-1 Antigen Rapid Test KitFast, Multi-Pathogen Detection for Efficient Respiratory Disease ScreeningRespiratory infections remain one of the most common causes of outpatient visits and public health screening worldwide. In clinical practice and large-scale screening scen

BIOTEKE's patented saliva pregnancy test kit represents a significant step forward in at-home diagnostics. This innovative test detects the presence of hCG in saliva, offering users a non-invasive, discreet, and user-friendly alternative.

Global Respiratory Infection Trends in 2025–2026: Why Rapid, Multiplex Diagnostics MatterRising Activity of Respiratory Pathogens WorldwideAcute respiratory infections remain one of the most common global causes of illness, especially in child, elderly, and immunocompromised populations. Seasonal in

Building the Health Silk Road: Bioteke Joins the Belt and Road Jiangsu Biopharmaceutical Industry Cooperation Event in WuxiA Gathering of Global Innovation in BiopharmaIn the golden season of autumn, the city of Wuxi became a center of international collaboration for the life sciences. On October 28

The First Affiliated Hospital of Zhengzhou University and Bioteke / Xijian Health Collaborate to Explore New Clinical Strategies for Type 2 Diabetes ManagementOn the morning of October 22, 2025, a seminar titled “The Effects of GCG/GLP-1 Dual Receptor Agonist Combined with High-Protein Meal Replacem

ORGANSAVE Tissue And Organ Preservation Fluid – Next-Generation Organ Transplant Solution

Discover Bioteke 5-in-1 Multiple Respiratory Multipathogen Antigen Test Kit, now with EU self-testing certification. Free samples available for EU medical distributors, wholesalers, hospitals, and pharmacies.

In May 2025, the World Health Organization (WHO) reported a noticeable increase in global SARS-CoV-2 activity, particularly in the Eastern Mediterranean, South-East Asia, and Western Pacific regions. Test positivity rates in some countries have reached as high as 11%, while regions like Europe, Africa, and the Americas report much lower rates, around 2–3%.